Newsroom | 5278 results

TEL AVIV, Israel & NEW YORK--(BUSINESS WIRE)--Longevity AI, a clinical intelligence company helping healthcare organizations deliver proactive, preventive care at scale, today announced a joint research collaboration with clinicians and researchers from Meir Medical Center of the Clalit Health Services Group. The research focuses on evaluating and refining clinical risk prediction models for cardiovascular disease and Type 2 diabetes, using longitudinal real-world data from Clalit’s integrated...

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced new peer-reviewed research suggesting that one of healthcare's most devastating and expensive chronic diseases may be far more preventable, and reversible, than previously recognized. Published in Diabetes, Obesity and Metabolism, this was one of the largest real-world studies of nutrition-based metabolic care, tracking more than 10,000 patients over 5 years. The findings revealed adults with type...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in the global Phase 3 YOSEMITE clinical trial of zodasiran, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that leads to severely elevated low density lipoprotein-cholesterol (LDL-C) and early onset cardiovascular disease. Arrowhe...

SAN DIEGO--(BUSINESS WIRE)--Dexcom (NASDAQ: DXCM), the global leader in glucose biosensing, today announced it is the first company selected by the U.S. Food and Drug Administration (FDA) to participate in the Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program, a first-of-its-kind initiative designed to evaluate innovative digital health technologies that improve chronic disease management while generating real-world evidence. Participation in the TEMPO pilot will allow Dexcom...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced that it has contributed to 12 new studies in the first six months of 2026, powered by high-quality real-world data from the Atropos Evidence™ Network and Atropos Health’s AI-driven real world evidence tools. This new collection of research and conference presentations spans multiple disease states and demonstrates how real-world evidence acce...

LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, has opened an innovative Phase 2 clinical trial designed to map how tumors change as they begin to resist immunotherapy, treatment that improves the immune system’s ability to fight disease. The research will focus on advanced non-small cell...

SCHILLER PARK, Ill.--(BUSINESS WIRE)--This release announces FDA 510(k) clearance for the SteriBest® sterilization tray system and OEM private-label options....

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it is divesting its Diabetes Health business to Cardinal Health. Under the terms of an agreement signed July 19, 2026, Cardinal Health will acquire AdaptHealth's Diabetes Health business for $235 million in cash, subject to...

ASTANA, Kazakhstan--(BUSINESS WIRE)--Carna Health signs MOU with Kazakhstan's Ministry of Health to advance cardio-kidney-metabolic syndrome prevention....

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts an...